RecruitingNCT07122427

Aging of the Vascular Wall


Sponsor

Centre Hospitalier Universitaire de Saint Etienne

Enrollment

30 participants

Start Date

Jul 17, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Demographic aging is predicted to be one of the most significant social changes of the 21st century. Aging is a slow, multifactorial process that progressively impacts the integrity of cells, tissues, and organs. This decline in function increases the risk of numerous diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases (CVD). CVD, the leading global cause of death, becomes more prevalent with age. Aging contributes to endothelial dysfunction, vessel stiffness, thickening, and impaired platelet function. These changes disrupt hemostatic processes and increase the risk of cardiovascular complications. Despite preventive strategies CVD remain a major public health challenge. Cellular aging, or senescence, affects all cell types, particularly endothelial cells and platelets. However, little research has compared the aging rates of different blood vessel types, such as arteries and veins. Given their distinct compositions and developmental origins, it is likely that their aging processes differ at molecular, cellular, and physiological levels.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Major patients requiring coronary artery bypass grafting (CABG).

Exclusion Criteria1

  • Hypertension, diabetes, systemic inflammatory disease.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREGraft collection

Sampling of superior venous and arterial grafts (internal mammary artery, great saphenous vein) after coronary artery bypass surgery.


Locations(1)

CHU Saint-Etienne

Saint-Etienne, France, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07122427


Related Trials